National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

STATUTORY RULES.

1958. No. 23.

REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1957.*

I THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1957.

Dated this  twenty-seventh

day of  March , 1958.

Governor-General.

By His Excellency’s Command,

Minister of State for Health.

Amendments of the National Health (Pharmaceutical Benefits) Regulations. 

Commencement.

1. These Regulations shall come into operation on the first day of April, 1958.

Pharmaceutical benefits for specified diseases or purposes.

2. Regulation 11 of the National Health (Pharmaceutical Benefits) Regulations is amended by omitting sub-regulation (2.) and inserting in its stead the following sub-regulation:—

“(2.) A medical practitioner may, in respect of a pensioner, prescribe a general pharmaceutical benefit the name or formula of which is specified in item 16, 37, 48, 49, 50, 51 or 53 in the Second Schedule for the treatment of any disease from which the pensioner is suffering.”.

Writing of prescription.

3. Regulation 17 of the National Health (Pharmaceutical Benefits) Regulations is amended—

(a) by omitting sub-regulation (3.) and inserting in its stead the following sub-regulation:—

“(3.) For the purposes of paragraph (d)of the last preceding sub-regulation, a prescription for the supply of two or more strengths of a form of a general pharmaceutical benefit the name or formula of which is specified in item 10, 14, 21, 111 or 136 in the First Schedule shall be deemed to prescribe one general pharmaceutical benefit.”; and

(b)by omitting from sub-regulation (4.) the words “the general pharmaceutical benefit Cortisone Acetate, Hydrocortisone, Prednisolone or Prednisone” and inserting in their stead the words and figures “a general pharmaceutical benefit the name or formula of which is specified in item 12, 23, 24, 41, 42, 43 or 44 in the Second Schedule”..

* Notified in the Commonwealth Gazette on  31st March  1958.

  Statutory Rules 1956, No. 54, as amended by Statutory Rules 1956, No. 75; and 1957, Nos. 25 and 52.

1643/55.—Price 9d. 9/20.3.1958.

Prescriptions of benefits in excessive quantities or for persons not entitled.

4. Regulation 19 of the National Health (Pharmaceutical Benefits) Regulations is amended—

(a)by omitting from paragraph (a) of sub-regulation (1.) the words “may be prescribed as a pharmaceutical benefit only for the treatment of a disease specified” and inserting in their stead the words “,at the time when the prescription was written, could be prescribed as a pharmaceutical benefit only for the treatment of a disease specified at that time”; and

(b)by omitting from sub-regulation (1.) the words “an amount equal to” and inserting in their stead the words “such amount (if any) as is determined by the Minister, being an amount not exceeding”.

Supply of pharmaceutical benefits on prescriptions.

5. Regulation 20 of the National Health (Pharmaceutical Benefits) Regulations is amended by omitting from sub-regulation (2.) the words “Cortisone Acetate, Hydrocortisone, Prednisolone or Prednisone as a pharmaceutical benefit” and inserting in their stead the words and figures “a general pharmaceutical benefit the name or formula of which is specified in item 12, 23, 24, 41, 42, 43 or 44 in the Second Schedule”.

Supply of pharmaceutical benefit before surrender of written prescription.

6. Regulation 21 of the National Health (Pharmaceutical Benefits) Regulations is amended—

(a)by omitting from sub-regulation (2.) the words “The pharmaceutical benefit Cortisone Acetate, Hydrocortisone, Prednisolone or Prednisone” and inserting in their stead the words and figures “A pharmaceutical benefit the name or formula of which is specified in item 12, 23, 24, 41, 42, 43 or 44 in the Second Schedule”; and

(b)by omitting from sub-regulation (4.) the words “Cortisone Acetate, Hydrocortisone, Prednisolone or Prednisone as a pharmaceutical benefit” and inserting in their stead the words and figures “a general pharmaceutical benefit the name or formula of which is specified in item 12, 23, 24, 41, 42, 43 or 44 in the Second Schedule”.

First Schedule.

7.The First Schedule to the National Health (Pharmaceutical Benefits) Regulations is repealed and the following Schedule inserted in its stead:—

First Schedule.

Regulation 10.

DRUGS AND MEDICINAL PREPARATIONS THAT MAY BE PRESCRIBED FOR SUPPLY, SUPPLIED AND RECEIVED AS GENERAL PHARMACEUTICAL BENEFITS.

Item No.	Name or Formula.
1	Acetarsol Soluble
2	Acetazolamide
3	Adrenalin in Oil
4	Adrenalin Tartrate
5	Aloxidone
6	Amidone
7	Amyl Nitrite
8	Antazoline
9	Atropine Sulphate
10	Aurothioglucose Oily

First Schedule—continued.

Item No.	Name or Formula.
11	Benzathine Penicillin with Procaine Penicillin and Potassium Penicillin
12	Benzhexol Hydrochloride
13	Bismuth Glycollylarsanilate
14	Calcium Aurothiomalate
15	Calf Lymph
16	Carbachol
17	Carbarsone
18	Carbimazole
19	Chiniofon
20	Chlormerodrin
21	Cholera Vaccine
22	Dapsone
23	Darrow’s Solution
24	Desacetyl-Lanatoside C
25	Dextrose Aqueous
26	Dextrose in 1/5 Normal Saline
27	Dextrose in Ringer’s Solution
28	Diethazine Hydrochloride
29	Diethylcarbamazine
30	Digitalis
31	Digitoxin
32	Digoxin
33	Dihydroergotamine
34	Dihydromorphinone
35	Diiodohydroxyquinoline
36	Dimercaprol
37	Diphenhydramine Hydrochloride
38	Diphtheria and Tetanus Toxoids Combined
39	Diphtheria Antitoxin
40	Diphtheria Pertussis Antigen
41	Diphtheria Pertussis and Tetanus Antigen
42	Diphtheria Prophylactic (Formalinized Toxoid)
43	Diphtheria Prophylactic (Purified Toxoid Aluminium Phosphate)
44	Diphtheria Toxoid Purified (diluted for skin test only)
45	Emetine Hydrochloride
46	Emetine Bismuth Iodide
47	Entero-Vioform
48	Ephedrine Hydrochloride
49	Ephedrine Sulphate
50	Ergometrine Maleate
51	Ergotamine Tartrate
52	Ethopropazine Hydrochloride
53	Ethoxzolamide
54	Ethyl Biscoumacetate
55	Ethylidene Dicoumarin
56	Gas Gangrene Antitoxin (Oedematiens)
57	Gas Gangrene Antitoxin (Perfringens)
58	Gas Gangrene Antitoxin (Polyvalent)
59	Gas Gangrene Antitoxin (Septique)
60	Glyceryl Trinitrate
61	Hartmann’s Solution
62	Hartmann’s Solution with Dextrose
63	Heparin
64	Heparin Retard
65	Hexamethonium Bromide
66	Hexamethonium Bromide with Ephedrine
67	Hexamethonium Tartrate
68	Hyaluronidase
69	Hyoscine Hydrobromide
70	Insulin
71	Insulin Globin Zinc
72	Insulin Isophane

First Schedule—continued.

Item No.	Name or Formula.
73	Insulin (Special P)
74	Insulin Protamine Zinc
75	Insulin Zinc
76	Isoprenaline Hydrochloride
77	Isoprenaline Sulphate
78	Leptazol
79	Mecamylamine
80	Mecholyl Chloride
81	Mepacrine Hydrochloride
82	Mepyramine Maleate
83	Mercaptomerin Sodium
84	Mercuramide with Theophylline
85	Mersalyl
86	Methoin
87	Methyl Atropine Nitrate
88	Methylergometrine Tartrate
89	Morphine Sulphate
90	Morphine with Atropine
91	Morphine with Hyoscine
92	Nalorphine Hydrobromide
93	Neoarsphenamine
94	Neostigmine Bromide
95	Neostigmine Methylsulphate
96	Nikethamide
97	Noradrenaline
98	Ouabain
99	Oxytocin
100	Pamaquin
101	Papaveretum
102	Papaveretum with Hyoscine Hydrobromide
103	Papaverine Hydrochloride
104	Paramethadione
105	Penicillin
106	Penicillin, Procaine
107	Pentaerythritol Tetranitrate
108	Pentolinium Tartrate
109	Pentolinium Tartrate with Ephedrine
110	Pertussis Prophylactic (Haemagglutinin Aluminium Phosphate Adsorbed)
111	Pertussis Vaccine (Phase 1)
112	Pethidine Hydrochloride
113	Pethidine Scopolamine
114	Phemitone
115	Phenobarbitone Sodium
116	Phenoxymethyl Penicillin
117	Phensuximide
118	Phenindione
119	Phenytoin Sodium
120	Phthalylsulphacetamide
121	Phthalylsulphathiazole
122	Picrotoxin
123	Pitressin Tannate in Oil
124	Primaquine Diphosphate
125	Primidone
126	Procainamide Hydrochloride
127	Procaine Hydrochloride in Normal Saline
128	Procyclidine Hydrochloride
129	Proguanil Hydrochloride
130	Promethazine Hydrochloride
131	Prophenpyridamine Para-Aminosalicylate
132	Protamine Sulphate
133	Pyridoxine Hydrochloride
134	Quinidine Sulphate

First Schedule—continued.

Item No.	Name or Formula.
135	Ringer’s Solution
136	Sodium Aurothiomalate
137	Sodium Calciumedetate
138	Sodium Chloride
139	Sodium Chloride with Dextrose
140	Sodium Lactate
141	Sodium Sulphate
142	Succinylsulphathiazole
143	Sulphadiazine
144	Sulphadiazine Sodium
145	Sulphadimidine
146	Sulphadimidine Sodium
147	Sulphafurazole
148	Sulphaguanidine
149	Sulphamerazine
150	Sulphamethizole
151	Sulphamethoxypyridazine
152	Sulphapyridine
153	Sulphathiazole
154	Sulphonamides, Mixed (A): Two Sulphonamides
155	Sulphonamides, Mixed (B): Three Sulphonamides
156	Sulphonamides, Mixed (C): Four Sulphonamides
157	Syntocinon
158	T.A.B. Vaccine (Anti-Typhoid-Para-Typhoid)
159	Tetanus Antitoxin
160	Tetanus Toxoid (Formalinized)
161	Tetanus Toxoid (Purified Aluminium Phosphate Adsorbed)
162	Theophylline with Ethylenediamine
163	Thiacetazone
164	Thiouracil, Methyl
165	Thiouracil, Propyl
166	Thyroid
167	Tiger Snake Anti-Venene
168	Triethanolamine Trinitrate
169	Troxidone
170	Vasopressin
171	Vitamin K
172	Water for Injection

Second Schedule.

8. The Second Schedule to the National Health (Pharmaceutical Benefits) Regulations is repealed and the following Schedule inserted in its stead:—

Second Schedule.

Regulation 11.

DRUGS AND MEDICINAL PREPARATIONS THAT MAY BE PRESCRIBED FOR SUPPLY, SUPPLIED AND RECEIVED AS GENERAL PHARMACEUTICAL BENEFITS ONLY FOR THE TREATMENT OF A DISEASE OR PURPOSE.

Item No.	Name or Formula.	Disease or Purpose.
1	Amodiaquine ................................	Malaria
Amoebiasis
Lupus erythematosus
2	Bemegride with Amiphenazole Hydrochloride	Antidote for barbiturate and other hypnotic poisons
3	Busulphan .....................................	The leukaemias
4	Calcium Benzoyl Para-Aminosalicylate (B-Pas)	Tuberculosis

Second Schedule—continued.

Item No.	Name or Formula.	Disease or Purpose.
5	Calcium Para-Aminosalicylate	Tuberculosis
6	Caramiphen Hydrochloride ..........	Parkinsonism
7	Chlorambucil ..............................	Malignant lymphoma and related conditions
8	Chloramphenicol .........................	Acute laryngo-tracheo-bronchitis
As an alternative to penicillin in the treatment of any disease in a person in whom penicillin sensitivity has been established
Bacillary dysentery that is resistant both to sulphonamides and streptomycin
Bacterium coli meningitis if other forms of treatment are unsuccessful
Brucellosis
Granuloma inguinale
Infections due to Friedlander bacillus
Infections due to haemophilus influenzae
Lymphogranuloma venereum
Salmonella infections
Severe gastro-enteritis in children
Staphylococcal infections
Surgical conditions of the bowel (pre-operative and post-operative)
Typhoid fever
Typhus and other rickettsial diseases
Urinary tract infections due to gram negative bacilli that do not respond to sulphonamides
Whooping cough (haemophilus pertussis)
9	Chloramphenicol Palmitate ..........	Any disease or purpose specified in this column in relation to chloramphenicol
10	Chloroquine Base ........................	Malaria
Amoebiasis
Lupus erythematosus
11	Chlortetracycline .........................	Actinomycosis
Acute and sub-acute bacterial endocarditis-streptococcus faecalis
Amoebiasis
As an alternative to penicillin in the treatment of any disease in a person in whom penicillin sensitivity has been established
Bacillary dysentery that is resistant both to sulphonamides and streptomycin
Brucellosis
Chancroid
Granuloma inguinale
Infections due to Friedlander bacillus
Leptospirosis
Lymphogranuloma venereum
Pneumonia that does not respond to penicillin or sulphonamides
Primary atypical pneumonia
Psittacosis
Puerperal infections
Rat-bite fever—spirillum minus
Staphylococcal infections
Trachoma that does not respond to sulphonamides
Typhus and other rickettsial diseases
Urinary tract infections due to gram negative bacilli that do not respond to sulphonamides
Whooping couth (haemophilus pertussis)
Mucoviscidosis

Second Schedule—continued.

Item No.	Name or Formula.	Disease or Purpose.
12	Cortisone Acetate ..........................	Acquired haemolytic anaemia
Acute exfoliative dermatitis associated with drug therapy
Acute rheumatic carditis
Addison’s disease and other forms of adrenocortical hypoplasia
Adrenogenital syndrome
Dermatomyositis
Panhypopituitarism
Pemphigus
Periarteritis nodosa
Pseudohermaphroditism
Sarcoidosis
Scleroderma
Status asthmaticus
Systemic lupus erythematosus
The leukaemias
Thrombocytopenic purpura
Total adrenalectomy
Still’s disease in children under the age of 16 years
Ulcerative colitis proven by sigmoidoscopy and radiological report
Henoch’s purpura
Posterior uveitis
Sympathetic ophthalmitis
13	Cyanocobalamin (strengths other than 1,000 microgramme strength)	Established megalocytic anaemias
14	Cyanocobalamin (1,000 micro-gramme strength)	Neuroblastoma
15	Deoxycortone Acetate ...................	Addison’s disease
16	Dienoestrol ...................................	Carcinoma of the prostate
Mammary carcinoma
17	Dihydrostreptomycin .....................	Any disease or purpose specified in this column in relation to streptomycin, but only if the person being treated for that disease or purpose is allergic to streptomycin
18	Dihydrotachysterol ........................	Parathyroid deficiency
19	Erythromycin ................................	Staphylococcal infections that are resistant both to the tetracyclines and to penicillin
20	Erythromycin Lactobionate	Any disease or purpose specified in this column in relation to erythromycin
21	Erythromycin Stearate ...................	The treatment of children under the age of 16 years in respect of any disease or purpose specified in this column in relation to erythromycin
22	Folic Acid ....................................	Sprue or the sprue-like syndrome Macrocytic anaemia
23	Hydrocortisone .............................	Any disease or purpose specified in this column in relation to cortisone acetate
24	Hydrocortisone Sodium Succinate ..	Acute adrenal failure due to a medical or surgical crisis
25	Isoniazid ......................................	Leprosy
Tuberculosis
26	Mercaptopurine ............................	The leukaemias
27	Methorphinan ...............................	Inoperable cancer
28	Mustine Hydrochloride ..	Malignant lymphoma and related conditions
29	Nitrofurantoin ..............................	Urinary tract infections
30	Nitromin ......................................	Malignant lymphoma and related conditions
31	Nystatin .......................................	Proven monilia infections

Second Schedule—continued.

Item No.	Name or Formula.	Disease or Purpose.
32	Nystatin (Suspension of) ................	The treatment of children under the age of 16 years in respect of any disease or purpose specified in this column in relation to nystatin
33	Oxytetracycline Dihydrate .............	Any disease or purpose specified in this column in relation to chlortetracycline
34	Oxytetracycline Hydrochloride	Any disease or purpose specified in this column in relation to chlortetracycline
35	Pancreatin .....................................	Fibrocystic disease of the pancreas
Pancreatico-duodenectomy
36	Para-Aminosalicylic Acid ..............	Tuberculosis
37	Penicillin .......................................	For the penicillin treatment of haemophiliacs
Nephritis in children under the age of 16 years
Prophylactic use in rheumatic fever or chorea in children under the age of 16 years
38	Penicillin with Streptomycin ..........	Endocarditis due to streptococcus faecalis
Endocarditis due to streptococcus viridans
39	Phenoxymethyl Penicillin ..............	Any disease or purpose specified in this column in relation to penicillin
40	Phenindamine Tartrate ...................	Parkinsonism
41	Prednisolone .................................	Any disease or purpose specified in this column in relation to cortisone acetate
42	Prednisolone with Magnesium Trisilicate and Aluminium Hydroxide	Any disease or purpose specified in this column in relation to cortisone acetate
43	Prednisone ....................................	Any disease or purpose specified in this column in relation to cortisone acetate
44	Prednisone with Magnesium	Any disease or purpose specified in this column
Trisilicate and Aluminium Hydroxide	in relation to cortisone acetate
45	Progesterone .................................	Habitual abortion
46	Progesterone Depot .......................	Habitual abortion
47	Pyridostigmine Bromide ................	Myasthenia gravis
48	Quinine Bisulphate ........................	Malaria
49	Quinine Dihydrochloride ...............	Malaria
50	Quinine Hydrochloride ..................	Malaria
51	Quinine Sulphate ...........................	Malaria
52	Sodium Para-Aminosalicylate	Tuberculosis
53	Stilboestrol ....................................	Carcinoma of the prostate Mammary carcinoma
54	Streptomycin .................................	Bacillary dysentery not responding to sulphonamides
Brucellosis
Chancroid
Endocarditis due to streptococcus faecalis
Endocarditis due to streptococcus viridans
Infections due to Friedlander bacillus
Infections due to haemophilus influenzae
Infections due to pseudomonas pyocyaneus
Plague
Rat-bite fever—streptobacillus moniliformis Salmonella infections
Surgical conditions of the bowel (pre-operative and post-operative)
Surgical conditions of the thoracic organs
Tuberculosis
Tularaemia
Urinary tract infections which do not respond to sulphonamides
55	Streptomycin Sulphate ...................	Any disease or purpose specified in this column in relation to streptomycin

 

Second Schedule—continued.

Item No.	Name or Formula.	Disease or Purpose.
56	Suprarenal Cortex Extract ..............	Adrenal failure
57	Testosterone ..................................	Mammary carcinoma
Castration
58	Testosterone Methyl ......................	Mammary carcinoma
Castration
59	Testosterone Oenanthate ................	Mammary carcinoma
Castration
60	Testosterone Phenyl Propionate	Mammary carcinoma
Castration
61	Testosterone Propionate .................	Mammary carcinoma
Castration
62	Tetracycline ..................................	Any disease or purpose specified in this column in relation to chlortetracycline
63	Tetracycline with Oleandomycin	Any disease or purpose specified in this column in relation to chlortetracycline
64	Tetracycline with Sodium Meta-phosphate	Any disease or purpose specified in this column in relation to chlortetracycline
65	Tetracycline with Sodium Meta-phosphate (Suspension of)	The treatment of children under the age of 16 years in respect of any disease or purpose specified in this column in relation to chlortetracycline
66	Tretamine .....................................	Malignant lymphoma and related conditions
67	Trimetaphan Camphor-sulphonate	Hypotensive for anaesthesia
68	Veriloid ........................................	Hypertensive crisis
69	Vitamin K1 ....................................	Antidote to anticoagulants

By Authority: A. J. Arthur, Commonwealth Government Printer, Canberra.